1. Role of MicroRNAs in Cardiac Disease with Stroke in Pregnancy.
- Author
-
Salma U, Alshaikh ABA, Alanazi MF, Alomair BM, Alruwaili M, and Alruwaili R
- Subjects
- Female, Humans, Pregnancy, Heart Diseases complications, Heart Diseases genetics, Hypertension complications, MicroRNAs genetics, Pre-Eclampsia genetics, Pregnancy Complications, Stroke etiology
- Abstract
Pregnancy-related cardiovascular disease with stroke remains a considerable source of higher maternal morbidity and mortality occurs in periods of pregnancy, delivery, and postpartum. It is essential to counsel the mother before pregnancy by an expert cardiologist and obstetric team to discuss any event related to preexistent cardiac or past preeclampsia for estimation of maternal and fetal risks. In pregnancy, the cardiac state includes hypertensive disorders, ischemic heart disease, valvular disease, and postpartum stroke. The incidence of stroke is increasing in pregnancy, particularly in postpartum, and its strong relationship with hypertensive disorders of pregnancy (preeclampsia). The combined cardiologist and obstetrics team requires during pregnancy mainly due to the approach to the management of a cardiac disease that subsequently prevents stroke postpartum. Therefore, a general perception of cardiac disease during pregnancy, delivery, and postpartum should be a core knowledge extent for all cardiovascular and clinicians. Many studies provided linked that deregulation of microRNAs (miRNAs) in maternal circulation and placenta tissue may development of pregnancy complications including preeclampsia considered a diagnostic marker. The desire of this review provides a detailed outline of current knowledge and dealing in this field with strength on the physiological changes during pregnancy., Competing Interests: The authors declare that they have no conflicts of interest., (Copyright © 2022 Umme Salma et al.)
- Published
- 2022
- Full Text
- View/download PDF